Visceral artery pseudoaneurysms in necrotizing pancreatitis: risk of early bleeding with lumen-apposing metal stents

Author(s):  
Mohamed Abdallah ◽  
Kornpong Vantanasiri ◽  
Shamar Young ◽  
Nabeel Azeem ◽  
Stuart K. Amateau ◽  
...  
2021 ◽  
Vol 160 (6) ◽  
pp. S-290
Author(s):  
Mohamed Abdallah ◽  
Kornpong Vantanasiri ◽  
Ahmed Dirweesh ◽  
Shamar Young ◽  
Nabeel Azeem ◽  
...  

2021 ◽  
Vol 93 (6) ◽  
pp. AB244
Author(s):  
Lotte Boxhoorn ◽  
Robert C. Verdonk ◽  
Marc G. Besselink ◽  
Marja A. Boermeester ◽  
Thomas Bollen ◽  
...  

2018 ◽  
Vol 63 (9) ◽  
pp. 2456-2465 ◽  
Author(s):  
Andreas Thorsen ◽  
Anders Malthe Borch ◽  
Srdan Novovic ◽  
Palle Nordblad Schmidt ◽  
Lise Lotte Gluud

Pancreatology ◽  
2021 ◽  
Vol 21 ◽  
pp. S39-S40
Author(s):  
L. Boxhoorn ◽  
R.C. Verdonk ◽  
M.G. Besselink ◽  
W. Curvers ◽  
S.M. van Dijk ◽  
...  

2020 ◽  
Vol 63 (3) ◽  
pp. E272-E277
Author(s):  
Thomas K. Maatman ◽  
Mark A. Heimberger ◽  
Kyle A. Lewellen ◽  
Alexandra M. Roch ◽  
Cameron L. Colgate ◽  
...  

2002 ◽  
Vol 9 (1) ◽  
pp. 38-47 ◽  
Author(s):  
Andreas Gabelmann ◽  
Johannes Görich ◽  
Elmar M. Merkle

Purpose: To review a 10-year experience with endovascular embolization of visceral artery aneurysms. Methods: Twenty-five patients (13 men; mean age 52.1 years, range 31–80) presented with VAAs of varying locations and etiologies: 10 splenic, 3 gastroduodenal, 2 pancreaticoduodenal, 3 hepatic, 3 superior mesenteric, 2 celiac, 1 left gastric, and 1 jejunoileal. Ten patients were asymptomatic; 7 aneurysms were ruptured. Transcatheter coil embolization was the treatment of choice in all patients. Results: Coil placement was initially (<7 days) successful in 23 (92%) patients. One superior mesenteric artery aneurysm remained perfused, and recurrent bleeding occurred 2 days after intervention in 1 case, but repeated embolization excluded the aneurysm. One patient with necrotizing pancreatitis died from sepsis 10 days after endovascular treatment and surgery (4% 30-day mortality). Long-term follow-up revealed excellent results after an average 48.7 months (range 14–75) with only 1 recurrence after 12 months. Conclusions: Embolotherapy is the treatment of choice in visceral artery aneurysms, regardless of etiology, location, or clinical presentation.


Sign in / Sign up

Export Citation Format

Share Document